DPP4 and metabolic dysfunction-associated steatotic liver disease: DPP4 is also a hepatokine [2], and levels of this enzyme have thus been seen to be elevated in chronic liver diseases including hepatitis C, hepatitis B, non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma.